Home Sectors Healthcare Latest Movement: IQVIA (NYSE: IQV)

Latest Movement: IQVIA (NYSE: IQV)

SHARE

IQVIA is in the medical diagnostics and research industry and trades as part of the healthcare sector. The company CEO is Ari Bousbib. IQVIA Inc is an information and technology-enabled healthcare service provider to the pharmaceutical services, biotechnology, and healthcare industries. The Commercial Solutions and Research and Development Solutions generate maximum revenue.

Previous Intraday Trading Performance:

The IQV stock showed a previous change of 1.44% with an open at 135.44 and a close of 136.38. It reached an intraday high of 137.62 and a low of 135.44.

SeekingAlpha:  Tracking Dan Loeb’s Third Point Portfolio – Q1 2019 Update

Liquidity:

The stock has a market cap of $26.9b with 197.2m shares outstanding, of which the float is 186.7m shares. Trading volume reached 957,457 shares compared to its average volume of 1,208,564 shares. Based on the current average volume and close price, the trading liquidity is good.

Historical Trading Performance:

Over the last five trading days, IQVIA shares returned 2.03% and in the past 30 trading days it returned -4.31%. Over three months, it changed -3.80%. In one year it has changed 34.02% and within that year its 52-week high was 146.10 and its 52-week low was 97.65. IQV stock is 39.67% above its 52 Week Low.

Our calculations show a 200 day moving average of 128.95 and a 50 day moving average of 138.82. Currently IQV stock is trading 5.76% above its 200 day moving average.

SeekingAlpha:  Tracking Dan Loeb’s Third Point Portfolio – Q1 2019 Update

Earnings:

The last annual fiscal EPS for the company was reported at 1.23 that ended on 31st of December 2018, which according to the previous close, that is a PE of 110.88. Based on 9 analyst estimates, the consensus EPS for the next quarter is 1.41. The TTM EPS is 5.12, which comes to a TTM PE of 26.64. Historically, the PE high was 145.60 and the PE low was 16.00. If the stock reached its PE low, that would represent a price of 81.91, which is a decrease of -39.94%.

Below was the last reported quarterly diluted earnings per share:

1stQtr of 2019 0.29
4thQtr of 2018 0.34
3rdQtr of 2018 0.29
2ndQtr of 2018 0.29
1stQtr of 2018 0.32

Base on our calculations, the intrinsic value per share is 116.77, which means it may be overvalued by -16.79%.

Indicators to Watch:

Short-interest was 3,438,517, which was 1.74% of shares outstanding. The short-interest ratio or days-to-cover ratio was 2.70. This stock has some short interest, but it may be normal and no cause for concern if long the position.

The current calculated beta is 0.79.

SeekingAlpha:  Wall Street Breakfast: May Departure Signals New Brexit Phase

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 3.35%, return on assets is 1.07%, profit margin is 2.64%, price-to-sales is 2.52 and price-to-book is 4.07.

Company Scores:

All scores are out of six:
 1  :Valuation Score
 1  :Past Performance Score
 2  :Financial Strength Score
 3  :Future Growth Score
 0  :Dividend Score
 1  :Overall Score

SHARE
John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.